TransMedics Group ( (TMDX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
TransMedics Group’s stock took a dive after Scorpion Capital released a critical short report, accusing the company of healthcare fraud and planning to petition the FDA to suspend approval for its Organ Care System. This led to a sharp drop in stock value as analysts adjusted their price targets and ratings, reflecting worries over the company’s regulatory and ethical issues.
More about TransMedics Group
YTD Price Performance: 9.10%
Average Trading Volume: 1,932,511
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $2.43B
For further insights into TMDX stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.